Resmed Inc (RMD)

Index:

ASX 100

 NULL
   
  • 52 Week High: NULL
  • 52 Week Low: $0.00
  • Currency: Australian Dollars
  • Shares Issued: 1,426.80m
Select chart: 1 week | 1 month | 3 month | 6 month
 

Current

1 week

Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-25 5,120.24 1,720.14 1,448.13¢ n/a n/a +442% 342.58¢ 0.0%
30-Jun-26 5,521.35 1,890.02 1,598.43¢ n/a n/a +10% 384.39¢ 0.0%
30-Jun-27 5,911.09 2,052.99 1,749.91¢ n/a n/a +10% 386.07¢ 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Forecast Ratios

Year Ending Revenue/Share Price/Revenue per Share
30-Jun-25 $3.59 0.00
30-Jun-26 $3.87 0.00
30-Jun-27 $4.14 0.00

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue ($m)
30-Jun-2026 5,521 5,518 n/a 5,484 5,486 n/a
30-Jun-2027 5,911 5,907 n/a 5,877 5,866 n/a
 
Earnings
30-Jun-2026 1598.43¢ 1603.98¢ n/a 1715.30¢ 1656.68¢ n/a
30-Jun-2027 1749.91¢ 1755.99¢ n/a 1871.75¢ 1804.97¢ n/a
 
Dividend
30-Jun-2026 384.39¢ 385.72¢ n/a 413.57¢ 412.38¢ n/a
30-Jun-2027 386.07¢ 387.41¢ n/a 416.57¢ 414.52¢ n/a
 
Recommendations
Strong Buy 4 4 4 4 4 0
Buy 6 6 6 6 7 0
Neutral 5 5 5 5 4 0
Sell 1 1 1 1 1 0
Strong Sell 1 1 1 1 0 0
No. of Brokers 17 17 17 17 16 0
 
Average Rec 6.62 6.62 6.62 6.62 7.19 n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 3: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 4: Forecast figures based on normalised accounts.

 

Resmed Inc Market Data

Currency Australian Dollars
% Change 0.00 %
52 Week High NULL
52 Week Low $0.00
Shares Issued 1,426.80m

What The Brokers Say

Strong Buy 4
Buy 6
Neutral 5
Sell 1
Strong Sell 1
Total 17
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page